- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Virtual Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder
This is a Virtual Event for PsychU Members in Alaska, Idaho, Oregon, and Washington.
Nonadherence is a serious problem that can compromise treatment effectiveness in psychiatry. This presentation will review the multidimensional factors that contribute to adherence, discuss consequences of poor adherence, and bring to light implementation strategies to address adherence.
Featuring
-
Chet Robachinski, MD
Psychiatric Director, Bailey-Boushay House, Seattle, WA; Founding Partner, Associates in Behavioral Health
-
Simon Kim, PharmD
Medical Science Liaison
Speaker Chet Robachinski, MD is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc. Speaker Simon Kim, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.